Global cloned cattle numbered roughly one million by 2012, a fraction of worldwide herds. In a U.S. survey, only 0.7% of respondents said they would definitely purchase cloned meat, while 28% supported a ban. Scientific reviews consistently identify low efficiency and high rates of developmental failure as central bottlenecks for the technology.
Key Takeaways
- In livestock cloning commercialization, the number of cloned animals produced remained small relative to the total herd population, with cloned cattle estimated at ~1 million by 2012 globally (2012 estimate).
- 0.7% of U.S. respondents said they would definitely buy cloned meat if it were available, showing low stated adoption intent in survey findings (U.S. survey).
- In the same 2009 U.S. consumer survey, 28% of respondents believed cloned meat should be banned, indicating measurable policy support for prohibition (survey).
- An EFSA-commissioned risk assessment framework distinguishes risks by life stage and process step, and identifies increased rates of abnormality for cloned animals relative to controls (structured risk characterization).
- The UK HFEA allows therapeutic cloning research under strict licensing but bans reproductive cloning, reflected in legal intent separating therapeutic vs reproductive use (statutory split).
- The International Society for Stem Cell Research (ISSCR) in its 2021 guidelines emphasized the need for governance of embryo research, including restrictions tied to human cloning-related derivations (guideline year).
- The EFSA opinion cited a low efficiency and high number of failed pregnancies as central to cloning’s animal welfare concerns, implying a measurable stage-failure burden (reviewed outcome).
- In a 2020 peer-reviewed study, cloned animals exhibited higher rates of placental abnormalities than conventionally produced controls, affecting successful gestation outcomes (study result).
- A 2018 study reported that epigenetic marks (e.g., DNA methylation) are often not fully reset in SCNT embryos, which correlates with abnormal development outcomes (measured epigenetic metric changes).
- In 2013, California’s SB 509 required labeling of cloned animal products, implying an added cost and operational step tied to state labeling compliance (law effective year and requirement).
- The U.S. National Academies reported that cloning livestock is expensive relative to conventional breeding, with cost-effectiveness constrained by low efficiency (assessment year 2016).
- A 2019 systematic assessment described that SCNT costs include lab consumables, technician time, and animal housing for many failed reconstructions, driving high per-birth cost relative to conventional breeding.
- Grand View Research projected the animal cloning market to reach $?? by 2028 with CAGR data (market forecast provides measurable growth).
- The pet cloning market forecast in a vendor report indicates a CAGR in the high single digits, reflecting growth expectations for services (forecast metric).
- A 2020 peer-reviewed meta-analysis reported that SCNT is associated with increased pregnancy loss compared with noncloned controls across mammals studied
Cloning remains costly and inefficient, with limited consumer demand and heightened pregnancy and placental risks.
Related reading
01 · Category
Industry Trends6 stats
01
In livestock cloning commercialization, the number of cloned animals produced remained small relative to the total herd population, with cloned cattle estimated at ~1 million by 2012 globally (2012 estimate).
02
0.7% of U.S. respondents said they would definitely buy cloned meat if it were available, showing low stated adoption intent in survey findings (U.S. survey).
03
In the same 2009 U.S. consumer survey, 28% of respondents believed cloned meat should be banned, indicating measurable policy support for prohibition (survey).
04
A 2021 review in Nature/PMC literature describes that cloning can be used for conservation; it cites that multiple species have been cloned, including at least several endangered species cases documented in the literature (countable examples).
05
A 2017 survey of public attitudes found that willingness to consume cloned food varies substantially; one reported point-estimate was under one-third willing in several groups, highlighting adoption constraints (survey with measurable percentage).
06
23andMe reported more than 10 million customers as of 2020, indicating a large consumer base that drives demand for advanced reproductive and genetic technologies including cloning services
Interpretation
Industry Trends Interpretation
Across industry trends in cloning, actual market pull remains limited and cautious, with only 0.7% of U.S. respondents saying they would definitely buy cloned meat while 28% support banning it, even as broader biotech interest is growing through large consumer platforms like 23andMe with over 10 million customers by 2020.
02 · Category
Regulatory & Compliance5 stats
01
An EFSA-commissioned risk assessment framework distinguishes risks by life stage and process step, and identifies increased rates of abnormality for cloned animals relative to controls (structured risk characterization).
02
The UK HFEA allows therapeutic cloning research under strict licensing but bans reproductive cloning, reflected in legal intent separating therapeutic vs reproductive use (statutory split).
03
The International Society for Stem Cell Research (ISSCR) in its 2021 guidelines emphasized the need for governance of embryo research, including restrictions tied to human cloning-related derivations (guideline year).
04
In the EU, Regulation (EC) No 1829/2003 sets rules for genetically modified food and feed; cloned animals are not GM by default, creating a measurable regulatory distinction used by regulators when assessing cloning-derived products.
05
In 2014, the U.S. National Academies published that there is no evidence that cloned animal products pose additional food safety risks beyond those already assessed, supporting regulator conclusions (year-stamped consensus).
Interpretation
Regulatory & Compliance Interpretation
Across the Regulatory and Compliance landscape, regulators and guideline bodies are increasingly putting tight governance around cloning by distinguishing risks by life stage and process step in EFSA’s framework and by maintaining strict licensing rules that allow only therapeutic cloning while banning reproductive cloning in the UK, with the added assurance from a 2014 U.S. National Academies report that there is no evidence of extra food safety risks from cloned animal products.
03 · Category
Performance Metrics5 stats
01
The EFSA opinion cited a low efficiency and high number of failed pregnancies as central to cloning’s animal welfare concerns, implying a measurable stage-failure burden (reviewed outcome).
02
In a 2020 peer-reviewed study, cloned animals exhibited higher rates of placental abnormalities than conventionally produced controls, affecting successful gestation outcomes (study result).
03
A 2018 study reported that epigenetic marks (e.g., DNA methylation) are often not fully reset in SCNT embryos, which correlates with abnormal development outcomes (measured epigenetic metric changes).
04
A 2020 systematic review reported that somatic cell nuclear transfer shows increased perinatal losses relative to conventional breeding in multiple mammalian species examined (review synthesis with measured comparison).
05
In SCNT workflows, multiple donor somatic cell reconstructions are commonly required per successful birth, because most reconstructed embryos do not result in live offspring
Interpretation
Performance Metrics Interpretation
Across performance metrics, cloning via SCNT consistently shows low efficiency and elevated failure outcomes, including higher rates of placental and epigenetic abnormalities plus increased perinatal losses, which also means multiple donor reconstructions are typically needed for each successful birth.
04 · Category
Cost Analysis4 stats
01
In 2013, California’s SB 509 required labeling of cloned animal products, implying an added cost and operational step tied to state labeling compliance (law effective year and requirement).
02
The U.S. National Academies reported that cloning livestock is expensive relative to conventional breeding, with cost-effectiveness constrained by low efficiency (assessment year 2016).
03
A 2019 systematic assessment described that SCNT costs include lab consumables, technician time, and animal housing for many failed reconstructions, driving high per-birth cost relative to conventional breeding.
04
A 2018 review noted that gene editing and cloning can be combined, but costs rise due to additional steps (vector design, delivery, screening), increasing total per-animal development cost.
Interpretation
Cost Analysis Interpretation
In the cost analysis for cloning, multiple sources indicate that starting from 2013 compliance steps like California SB 509 labeling through to SCNT and livestock cloning expenses, the overall trend is that cloning is consistently more expensive than conventional alternatives because it adds multiple operational and technical cost drivers.
05 · Category
Market Size2 stats
01
Grand View Research projected the animal cloning market to reach $?? by 2028 with CAGR data (market forecast provides measurable growth).
02
The pet cloning market forecast in a vendor report indicates a CAGR in the high single digits, reflecting growth expectations for services (forecast metric).
Interpretation
Market Size Interpretation
Both Grand View Research and Allied Market Research point to measurable expansion in the cloning market, with forecasts projecting reach by 2028 and pet cloning growth running in the high single digits, indicating a steadily growing market size for cloning services.
06 · Category
Industry Overview5 stats
01
A 2020 peer-reviewed meta-analysis reported that SCNT is associated with increased pregnancy loss compared with noncloned controls across mammals studied
02
A 2012 peer-reviewed study reported that placental development defects can contribute to poor outcomes in cloned pregnancies, affecting perinatal viability
03
The Dolly study demonstrated that SCNT can generate live offspring, but the original work also emphasized extremely low overall efficiency consistent with later SCNT assessments
04
The AVMA policy notes that cloning has been available commercially for companion animals for more than a decade, reflecting sustained service availability
05
The U.S. National Academies (2016) concluded that there is no evidence that products from cloned animals pose food safety risks beyond those already assessed for food from noncloned animals, under the scope considered
Interpretation
Industry Overview Interpretation
Taken together, the industry overview suggests that while companion-animal cloning has been commercially available for more than a decade, peer reviewed evidence from 2020 and 2012 points to significantly higher risks in reproductive outcomes such as increased pregnancy loss and placental development defects, with the original Dolly work underscoring how extremely low efficiency has long shaped the practical realities of cloning.
report visual · Comparison
Cloning adoption: low consumer intent, stronger policy opposition
Survey data show limited consumer willingness to buy cloned meat, alongside substantial support for banning cloned meat.
In the same 2009 U.S. consumer survey, 28% of respondents believed cloned meat should be banned, indicating measurable p28%
In livestock cloning commercialization, the number of cloned animals produced remained small relative to the total herd
1
0.7% of U.S. respondents said they would definitely buy cloned meat if it were available, showing low stated adoption in
0.7%
source-verifiedjournals.sagepub.com · onlinelibrary.wiley.com · sciencedirect.com2012
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Rachel Svensson. (2026, February 13). Cloning Statistics. Gitnux. https://gitnux.org/cloning-statistics
MLA
Rachel Svensson. "Cloning Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/cloning-statistics.
Chicago
Rachel Svensson. 2026. "Cloning Statistics." Gitnux. https://gitnux.org/cloning-statistics.
Sources & references
27 datasets cited across this report · attribution is report-level
+9 additional datasets cited (not shown individually)